The Use of Lithium in the Treatment of Thyrotoxicosis
AUTOR(ES)
Temple, R.
RESUMO
Since lithium has been shown to inhibit release of iodine from the thyroid, we have investigated its therapeutic potential in thyrotoxicosis. Eight detailed 131I kinetic studies were performed on seven thyrotoxic women and data was analyzed using a computer program. Lithium at serum levels of about 1 mEq liter decreased the loss of 131I from the thyroid, led to a fall in serum 131I levels and diminished urinary 131I excretion. Computer simulation of the lithium effect required, in every case, that lithium inhibit hormonal and nonhormonal thyroid iodine release. In five cases a second lithium effect was required for a satisfactory fit of the model soluton with observed data: namely, an inhibition of hormone disappearance from serum.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=332975Documentos Relacionados
- Histological features of the thyroid gland in a patient with lithium induced thyrotoxicosis.
- Psychiatry—Important Advances in Clinical Medicine: Use of Lithium Carbonate in Psychiatric Treatment
- Assessment of thyroid function during and after treatment of thyrotoxicosis.
- THE TREATMENT OF MANIC PSYCHOSES BY THE ADMINISTRATION OF LITHIUM SALTS
- Soluble interleukin-2 receptor is a thyroid hormone-dependent early-response marker in the treatment of thyrotoxicosis.